The quality of dialysate: An integrated approach

被引:66
作者
Lonnemann, GR [1 ]
机构
[1] Gemeinschaftspraxis Nephrol & Dialyse, D-30851 Langenhagen, Germany
关键词
biocompatibility; endotoxin; bacteria; hemodialysis; chronic inflammatory disease;
D O I
10.1046/j.1523-1755.2000.07614.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The role of bacterial contamination of dialysis water with respect to chronic inflammatory diseases associated with long-term hemodialysis therapy has been greatly underestimated in the last two decades. In the present article, recent multicenter studies assessing the bacteriological quality of water and dialysate are discussed. In addition, we describe that pyrogenic substances of bacterial origin derived from contaminated dialysate penetrate intact dialyzer membranes with the consequence of the induction of an Inflammatory response in the patients. The influence of dialyzer membrane characteristics on the passage of bacterial substances from dialysate into blood are discussed. Reaching the patients blood, bacteria-derived substances activate circulating mononuclear cells to produce proinflammatory cytokines. Cytokines such as interleukin-1 beta and tumor necrosis factor-ex are mediators of the acute phase response resulting in elevated levels of acute phase proteins (for example, C-reactive protein). The consequence is a state of microinflammation that may contribute to progressive inflammatory diseases in chronic renal failure such as beta(2)-microglobulin amyloidosis, protein catabolism, and atherosclerosis. The use of sterile dialysate reduces cytokine production and plasma levels of acute phase proteins, and may positively influence progressive inflammatory diseases in patients with end-stage renal failure.
引用
收藏
页码:S112 / S119
页数:8
相关论文
共 34 条
[1]   Microbiological quality of water and dialysate in all haemodialysis centres of Greece [J].
Arvanitidou, M ;
Spaia, S ;
Katsinas, C ;
Pangidis, P ;
Constantinidis, T ;
Katsouyannopoulos, V ;
Vayonas, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (04) :949-954
[2]   Contamination of dialysis water and dialysate: A survey of 30 centers [J].
Bambauer, R. ;
Schauer, M. ;
Jung, W.K. ;
Daum, V. ;
Vienken, J. .
ASAIO Journal, 1994, 40 (04) :1012-1016
[3]   USING ULTRAPURE WATER IN HEMODIALYSIS DELAYS CARPAL-TUNNEL SYNDROME [J].
BAZ, M ;
DURAND, C ;
RAGON, A ;
JABER, K ;
ANDRIEU, D ;
MERZOUK, T ;
PURGUS, R ;
OLMER, M ;
REYNIER, JP ;
BERLAND, Y .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (11) :681-685
[4]   Infection and atherosclerosis -: Focus on cytomegalovirus and Chlamydia pneumoniae [J].
Cheng, JM ;
Rivera, NG .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (12) :1310-1316
[5]   Mechanisms of loss of lean body mass in patients on chronic dialysis [J].
Dinarello, CA ;
Roubenoff, RA .
BLOOD PURIFICATION, 1996, 14 (05) :388-394
[6]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[7]   Infection and atherosclerosis - Emerging mechanistic paradigms [J].
Epstein, SE ;
Zhou, YF ;
Zhu, JH .
CIRCULATION, 1999, 100 (04) :E20-E28
[8]   INVITRO STUDY OF THE TRANSFER OF CYTOKINE-INDUCING SUBSTANCES ACROSS SELECTED HIGH-FLUX HEMODIALYSIS MEMBRANES [J].
EVANS, RC ;
HOLMES, CJ .
BLOOD PURIFICATION, 1991, 9 (02) :92-101
[9]   Human monocyte-endothelial cell interaction induces platelet-derived growth factor expression [J].
Funayama, H ;
Ikeda, U ;
Takahashi, M ;
Sakata, Y ;
Kitagawa, SI ;
Takahashi, YI ;
Masuyama, JI ;
Furukawa, Y ;
Miura, Y ;
Kano, S ;
Matsuda, M ;
Shimada, K .
CARDIOVASCULAR RESEARCH, 1998, 37 (01) :216-224
[10]   Advanced glycated end-products (AGE) during haemodialysis treatment:: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds [J].
Henle, T ;
Deppisch, R ;
Beck, W ;
Hergesell, O ;
Hänsch, GM ;
Ritz, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) :1968-1975